Effects of Hemoperitoneum Driven Carbon Monoxide on Post-Traumatic Stability and Platelet Aggregation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01594034 |
Recruitment Status :
Completed
First Posted : May 8, 2012
Last Update Posted : May 14, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Hemoperitoneum | Procedure: expired air |
Study Type : | Observational |
Actual Enrollment : | 9 participants |
Time Perspective: | Prospective |
Official Title: | Effects of Hemoperitoneum Driven Carbon Monoxide on Post-Traumatic Stability |
Study Start Date : | November 2009 |
Actual Primary Completion Date : | May 2011 |
Actual Study Completion Date : | May 2011 |
Group/Cohort | Intervention/treatment |
---|---|
no treatment |
Procedure: expired air
collection of expired air from ventilator |
- •Establish a method for reliably measuring CO excretion in patients. [ Time Frame: 96 hours ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Hospitalized males 18 years of age or older,
- Diagnosis of isolated blunt OR blunt and penetrating trauma,
- Admitted or expecting to be admitted to the Intensive Care Unit,
- On mechanical ventilation, and
- Written informed consent obtained
Exclusion Criteria:
- Female gender, (Females will be excluded from this study as the menstrual cycle and other estrogen variations are known to be associated with cyclic changes in CO production adding a potential confounder to the interpretations of our findings.)
- Diagnosis of isolated penetrating trauma,
- Acute hemothorax or pneumothorax,
- Treatment with antiaggregants (ASA, clopidogrel, aggrenox or ticlopidine),
- Enrollment in another research study,
- Prisoners,
- Inability to perform CO measurement within 96 hours after hospital admission.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01594034
United States, Texas | |
University Hospital | |
San Antonio, Texas, United States, 78229 |
Principal Investigator: | Robert Johnson, PhD | University of Texas |
Responsible Party: | The University of Texas Health Science Center at San Antonio |
ClinicalTrials.gov Identifier: | NCT01594034 |
Other Study ID Numbers: |
HSC-2009-0176-H |
First Posted: | May 8, 2012 Key Record Dates |
Last Update Posted: | May 14, 2012 |
Last Verified: | May 2012 |
Hemoperitoneum Peritoneal Diseases Digestive System Diseases Hemorrhage Pathologic Processes |